Pharmaceuticals for Women’s Health Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Table of Contents

Chapter 1           Prefix.

1.1          Research Description.

1.2          Research Scope.

1.3          Research Methodology.

Chapter 2           Executive Summary.

Chapter 3           Market Outline.

3.1          Market Inclination, Trend, Outlook and Viewpoint

3.2          Market Share Analysis: Company’s Competitive Scenario.

3.3          Market Dynamics.

3.3.1       Drivers

3.3.1.1         Growing incidence of chronic health conditions among women.

3.3.1.2         Government initiatives to curb population growth.

3.3.1.3         Growing demand for contraceptives to prevent unintended pregnancies

3.3.1.4         Huge change in the lifestyle of women as compared to the last one decade.

3.3.1.5         Impact Analysis

3.3.2       Restraints

3.3.2.1         Social norms discouraging equality in women.

3.3.2.1         Lack of awareness about women health disorders

3.3.3       Opportunity

3.3.3.1         Untapped regional markets of Asia Pacific and Rest of the World

3.3.3.2         Rise in R&D program by key players for the development of advanced products

Chapter 4           Global Pharmaceuticals for Women’s Health Market, by Health Disorders

4.1          Overview

4.1.1       Global Pharmaceuticals for Women’s Health market share and forecast, by Equipment Type 2018 Vs 2025 (Value %)

4.2          Postmenopausal Osteoporosis.

4.2.1       Current Trend and Analysis

4.2.2       Postmenopausal Osteoporosis Market Size And Forecast, 2016 – 2025 ($ MILLION)

4.3          Menopause-Related Diseases.

4.3.1       Current Trend and Analysis

4.3.2       Menopause-Related Diseases Market Size And Forecast, 2016 – 2025 ($ MILLION)

4.4          Endometriosis.

4.4.1       Current Trend and Analysis

4.4.2       Endometriosis Market Size And Forecast, 2016 – 2025 ($ MILLION)

4.5          Polycystic Ovary Syndrome (PCOS)

4.5.1       Current Trend and Analysis

4.5.2       Polycystic Ovary Syndrome (PCOS) Market Size And Forecast, 2016 – 2025 ($ MILLION)

4.6          Pregnancy Disorders And Management

4.6.1       Current Trend and Analysis

4.6.2       Pregnancy Disorders And Management Market Size And Forecast, 2016 – 2025 ($ MILLION)

4.7          Other.

4.7.1       Current Trend and Analysis

4.7.2       Other Market Size And Forecast, 2016 – 2025 ($ MILLION)

Chapter 5           Global Pharmaceuticals for Women’s Health Market, By Geography, 2016 - 2025

5.1          Overview

5.2          North America.

5.2.1       Current Trend and Analysis

5.2.2       North America Pharmaceuticals for Women’s Health Market size and forecast by Country, 2018 – 2026 ($Million)

5.2.2.1         U.S. Pharmaceuticals for Women’s Health Market

5.2.2.2         U.S. Pharmaceuticals for Women’s Health Market Size and Forecast, 2018 – 2026 ($Million)

5.2.2.3         Canada Pharmaceuticals for Women’s Health Market

5.2.2.4         Canada Pharmaceuticals for Women’s Health Market Size And Forecast, 2016 – 2025 ($Million)

5.2.2.5         Mexico Pharmaceuticals for Women’s Health Market

5.2.2.6         Mexico Pharmaceuticals for Women’s Health Market Size And Forecast, 2016 – 2025 ($Million)

5.3          Europe.

5.3.1       Current Trend and Analysis

5.3.2       Europe Pharmaceuticals for Women’s Health Market Size And Forecast, 2016 – 2025 By Country, ($Million)

5.3.2.1         U.K. Pharmaceuticals for Women’s Health Market

5.3.2.2         U.K. Pharmaceuticals for Women’s Health Market Size And Forecast, 2016 – 2025 ($Million)

5.3.2.3         France Pharmaceuticals for Women’s Health Market

5.3.2.4         France Pharmaceuticals for Women’s Health Market Size And Forecast, 2016 – 2025 ($Million)

5.3.2.5         Germany Pharmaceuticals for Women’s Health Market

5.3.2.6         Germany Pharmaceuticals for Women’s Health Market Size And Forecast, 2016 – 2025 ($Million)

5.3.2.7         Spain Pharmaceuticals for Women’s Health Market

5.3.2.8         Spain Pharmaceuticals for Women’s Health Market Size And Forecast, 2016 – 2025 ($ MILLION)

5.3.2.9         Others Pharmaceuticals for Women’s Health Market

5.3.2.10        Others Pharmaceuticals for Women’s Health Market Size and Forecast, 2016 – 2025 ($ MILLION)

5.4          Asia-Pacific.

5.4.1       Current Trend and Analysis

5.4.2       Asia-Pacific Pharmaceuticals for Women’s Health Market Size and Forecast, 2016 – 2025 By Country ($ Million)

5.4.2.1         China Pharmaceuticals for Women’s Health Market

5.4.2.2         China Pharmaceuticals for Women’s Health Market Size and Forecast, 2016 – 2025 ($Million)

5.4.2.3         India Pharmaceuticals for Women’s Health Market

5.4.2.4         India Pharmaceuticals for Women’s Health Market Size And Forecast, 2016 – 2025 ($Million)

5.4.2.5         Japan Pharmaceuticals for Women’s Health Market

5.4.2.6         Japan Pharmaceuticals for Women’s Health Market Size And Forecast, 2016 – 2025 ($Million)

5.4.2.7         South Korea Pharmaceuticals for Women’s Health Market

5.4.2.8         South Korea Pharmaceuticals for Women’s Health Market Size And Forecast, 2016 – 2025 ($ MILLION)

5.4.2.9         Others Pharmaceuticals for Women’s Health Market

5.4.2.10        Others Pharmaceuticals for Women’s Health Market Size And Forecast, 2018 – 2026 ($Million)

5.5          Rest of the World.

5.5.1       Current Trend and Analysis

5.5.2       Rest of the World Pharmaceuticals for Women’s Health Market size and forecast, 2018 – 2026, by Country ($Million)

5.5.2.1         South America Pharmaceuticals for Women’s Health Market

5.5.2.2         South America Pharmaceuticals for 2016 – 2025 Women’s Health Market Size And Forecast, 2018 – 2026 ($Million)

5.5.2.3         Middle East Pharmaceuticals for Women’s Health Market

5.5.2.4         Middle East Pharmaceuticals for Women’s Health Market Size And Forecast, 2016 – 2025 ($ MILLION)

5.5.2.5         Africa Pharmaceuticals for Women’s Health Market

5.5.2.6         Africa Pharmaceuticals for Women’s Health Market Size And Forecast, 2018 – 2026 ($Million)

Chapter 6           Company Profiles

6.1          Amgen (US)

6.1.1       Company Overview

6.1.2       Operating Business Segments

6.1.3       Financials Revenue 2017 and 2018.

6.1.4       Business Strategies

6.2          Abbvie Inc.

6.2.1       Company overview

6.2.1       Operating Business Segments

6.2.2       Financials

6.2.3       Business Strategies

6.3          Allergan Plc.

6.3.1       Company overview..

6.3.2       Operating Business Segments

6.3.3       Financials

6.3.4       Business Strategies

6.4          Bayer AG

6.4.1       Company overview

6.4.2       Operating Business Segments

6.4.3       Financials

6.4.4       Business Strategies

6.5          Daiichi Sankyo Company. Ltd.

6.5.1       Company overview..

6.5.2       Operating Business Segments

6.5.3       Financials

6.5.4       Business Strategies

6.6          Eli Lilly And Company,

6.6.1       Company overview..

6.6.2       Operating Business Segments

6.6.3       Financials

6.6.4       Business Strategies

6.7          Johnson & Johnson Inc.

6.7.1       Company overview..

6.7.2       Operating Business Segments

6.7.3       Financials

6.7.4       Business Strategies

6.8          Merck & Co. Inc.

6.8.1       Company overview..

6.8.2       Operating Business Segments

6.8.3       Financials

6.8.4       Business Strategies

6.9          Novo Nordisk.

6.9.1       Company overview..

6.9.2       Operating Business Segments

6.9.3       Financials

6.9.4       Business Strategies

6.10        Pfizer Inc.

6.10.1      Company overview..

6.10.2      Operating Business Segments

6.10.3      Financials

6.10.4      Business Strategies

6.11        Others.

 

 

List of Figures

 

FIG. 1             MARKET SEGMENTATION: GLOBAL PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET 

FIG. 2             MARKET SHARE ANALYSIS: COMPANY’S COMPETITIVE SCENARIO, 2019 (%)

FIG. 3             GLOBAL PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SHARE AND FORECAST, BY EQUIPMENT TYPE 2018 Vs 2026 (VALUE %)

FIG. 4             TREADMILLS MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 5             MENOPAUSE-RELATED DISEASES MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 6             ENDOMETRIOSIS MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 7             POLYCYSTIC OVARY SYNDROME (PCOS) MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 8             PREGNANCY DISORDERS AND MANAGEMENT MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 9             OTHER MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 10           GLOBAL PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST BY GEOGRAPHY, 2018 Vs 2025 (REVENUE )

FIG. 11           NORTH AMERICA PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 12           NORTH AMERICA PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST BY COUNTRY, 2016 – 2025 ($ MILLION)

FIG. 13           U.S. PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 14           CANADA PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 15           MEXICO PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 16           EUROPE PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2018 – 2025 BY COUNTRY, ($ MILLION)

FIG. 17           U.K. PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 18           FRANCEPHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 19           GERMANY PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 20           SPAIN PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 21           OTHERSPHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 22           ASIA-PACIFIC PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2018 – 2026 BY COUNTRY ($ MILLION)

FIG. 23           CHINA PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 24           INDIA PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 25           JAPAN PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 26           SOUTH KOREAPHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 27           OTHERS PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 28           REST OF THE WORLD PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2018 – 2025 BY COUNTRY ($ MILLION)

FIG. 29           SOUTH AMERICA PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 30           MIDDLE EAST PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)

FIG. 31           AFRICA PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SIZE AND FORECAST, 2016 – 2025 ($ MILLION)


 

List of Tables

TABLE 1          GLOBAL PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET SNAPSHOT 

TABLE 2          GLOBAL PHARMACEUTICALS FOR WOMEN’S HEALTH MARKET, 2016 - 2025, BY HEALTH DISORDERS, 2016 – 2025 ($ MILLION)

TABLE 3          POSTMENOPAUSAL OSTEOPOROSIS MARKET SIZE AND FORECAST, BY REGION, 2016 – 2025 ($ MILLION)

TABLE 4          NORTH AMERICA POSTMENOPAUSAL OSTEOPOROSIS MARKET SIZE AND FORECAST, BY COUNTRY, 2016 – 2025 ($ MILLION)

TABLE 5          EUROPE POSTMENOPAUSAL OSTEOPOROSIS MARKET SIZE AND FORECAST, BY COUNTRY, 2016 – 2025 ($ MILLION)

TABLE 6          ASIA PACIFIC POSTMENOPAUSAL OSTEOPOROSIS MARKET SIZE AND FORECAST, BY COUNTRY, 2016 – 2025 ($ MILLION)

TABLE 7          REST OF THE WORLD (ROW) POSTMENOPAUSAL OSTEOPOROSIS MARKET SIZE AND FORECAST, BY COUNTRY, 2016 – 2025 ($ MILLION)

TABLE 8          MENOPAUSE-RELATED

Back to top

Payment Options

Single User $3897
Five User $5175
Enterprise $9135
Datapack $1299
Short Report: $1799